Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140,013 | 146,972 | 173,082 | 168,461 | 181,741 |
| Marketable Securities | 178,013 | 223,284 | 262,836 | 240,157 | 281,589 |
| Receivables | 5,849 | 7,150 | 3,421 | 1,693 | 3,750 |
| Inventories | 7,873 | 6,123 | 7,082 | 3,248 | 1,099 |
| Other current assets | 9,880 | 10,835 | 7,773 | 8,109 | 0 |
| TOTAL | $353,327 | $403,692 | $478,882 | $436,237 | $477,923 |
| Non-Current Assets | |||||
| PPE Net | 5,236 | 4,921 | 5,358 | 5,393 | 5,217 |
| Investments And Advances | 0 | 10,881 | 20,777 | 42,514 | 71,076 |
| Intangibles | 7,279 | 7,423 | 7,567 | 7,710 | 7,851 |
| Other Non-Current Assets | 20,577 | 20,788 | 14 | 4,812 | 9,609 |
| TOTAL | $33,092 | $44,013 | $33,716 | $60,429 | $93,753 |
| Total Assets | $386,419 | $447,705 | $512,598 | $496,666 | $571,676 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,215 | 15,163 | 6,746 | 20,788 | 9,304 |
| Accrued Expenses | 42,141 | 25,968 | 46,471 | 27,746 | 48,525 |
| TOTAL | $69,005 | $61,081 | $71,579 | $57,508 | $80,524 |
| Non-Current Liabilities | |||||
| Long Term Debt | 203,554 | 201,749 | 200,236 | 107,397 | 104,816 |
| Deferred Revenues | 1,847 | 2,358 | 4,928 | 3,861 | 11,169 |
| Other Non-Current Liabilities | 19,143 | 12,736 | 15,305 | 16,513 | 17,765 |
| TOTAL | $226,847 | $219,696 | $220,958 | $128,990 | $141,659 |
| Total Liabilities | $295,852 | $280,777 | $292,537 | $186,498 | $222,183 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,821 | 66,434 | 66,086 | 65,825 | 65,392 |
| Common Shares | 68 | 67 | 66 | 67 | 66 |
| Retained earnings | -1,525,704 | -1,437,156 | -1,365,853 | -1,259,660 | -1,204,519 |
| Other shareholders' equity | 1,883 | 2,067 | 1,704 | 1,375 | 2,218 |
| TOTAL | $90,567 | $166,928 | $220,061 | $310,168 | $349,493 |
| Total Liabilities And Equity | $386,419 | $447,705 | $512,598 | $496,666 | $571,676 |